Patent Assignment
Reel/Frame 043952/0150
Security Interest
Recorded: 2017-09-22
Pages: 78
Assignor
CYTORI THERAPEUTICS, INC.
Executed: 2017-09-20
Assignee
OXFORD FINANCE LLC, AS COLLATERAL AGENT
133 NORTH FAIRFAX STREET, ALEXANDRIA, VIRGINIA, 22314
Covered Properties
(71)
Systems and Method for Treating Patients with Processed Lipoaspirate Cells
PCT:
PCT/US2002/039465 ↗
Protein-Stabilized Liposomal Formulations of Pharmaceutical Agents
PCT:
PCT/US2003/035297 ↗
Method of Using Adipose Tissue-Dervied Conditions
PCT:
PCT/US2004/005117 ↗
Methods of Using Adipose Tissue-Derived Cells in Augmenting Autologous Fat Transfer
PCT:
PCT/US2004/019611 ↗
Systems and Methods for Separating and Concentrating Regenerative Cells from Tissue
PCT:
PCT/US2004/020594 ↗
Systems and Methods for Isolating and Using Clinically Safe Adipose Derived Regenerative Cells
PCT:
PCT/US2004/021391 ↗
Methods of Using Regenerative Cells to Promote Wound Healing
PCT:
PCT/US2004/021415 ↗
Cell Carrier and Cell Carrier Containment Devices Containing Regenerative Cells
PCT:
PCT/US2004/021417 ↗
Methods of Using Regenerative Cells in the Treatment of Musculoskeletal Disorders
PCT:
PCT/US2004/021419 ↗
Methods of Using Regenerative Cells in the Treatment of Peripheral Vascular Disease and Related Disorders
PCT:
PCT/US2004/021480 ↗
Methods of Using Regenerative Cells in the Treatment of Stroke and Related Diseases and Disorders
PCT:
PCT/US2004/021483 ↗
Methods of Using Regenerative Cells in the Treatment of Renal Diseases and Disorders
PCT:
PCT/US2004/021549 ↗
Devices and Methods for Monitoring, Managing, and Servicing Medical Devices
PCT:
PCT/US2005/001267 ↗
Methods of Using Adipose Tissue-Derived Cells in the Treatment of Cardiovascular Conditions
PCT:
PCT/US2005/018605 ↗
Methods of Using Adipose Tissue-Derived Cells in the Modulation of Inflammation
PCT:
PCT/US2010/032275 ↗
Centrifuge Chamber
PCT:
PCT/US2015/039250 ↗
Use of Regenerative Cells in Mitigating Burn Progression and Improving Skin Graft Incorporation and Healing
PCT:
PCT/US2015/053856 ↗
Regenerative Cell Therapy for Musculoskeletal Disorders
PCT:
PCT/US2016/056043 ↗
Fabricated Tee
Patent:
4,653,952 →
Application:
06/770,119 →
Shift Lever Assembly for Power Transmission of Automotive Vehicle
Patent:
5,575,174 →
Application:
08/502,457 →
Filter Unit Which Is Adapted for Miniaturization
Patent:
5,883,553 →
Application:
08/921,474 →
Systems and Methods for Treating Patients with Processed Lipoaspirate Cells
Systems and Methods for Treating Patients with Processed Lipoaspirate Cells
Method for Processing Lipoaspirate Cells
Self-Contained Adipose Derived Stem Cell Processing Unit
Autologous Adipose Tissue Implant with Concentrated Stem Cells
Protein-Stabilized Liposomal Formulations of Pharmaceutical Agents
Methods of Using Adipose Tissue-Derived Cells in Augmenting Autologous Fat Transfer
Systems and Methods for Separating and Concentrating Adipose Derived Stem Cells from Tissue
Methods of Using Regenerative Cells in the Treatment of Musculoskeletal Disorders
Automated Methods for Isolating and Using Clinically Safe Adipose Derived Regenerative Cells
Methods of Using Adipose Derived Stem Cells to Treat Acute Tubular Necrosis
Methods of Using Adipose Derived Stem Cells to Promote Wound Healing
Method for Processing and Using Adipose-Derived Stem Cells
Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
Systems and Methods for Treating Patients with Processed Lipoaspirate Cells
Systems and Methods for Isolating and Using Clinically Safe Adipose Derived Regenerative Cells
Methods of Using Adipose Tissue-Derived Cells in Augmenting Autologous Fat Transfer
Methods of Using Adipose Derived Regenerative Cells to Promote Restoration of Intevertebral Disc
Methods of Making Enhanced, Autologous Fat Grafts
Methods of Making Enhanced, Autologous Fat Grafts
Methods of Using Adipose Tissue-Derived Cells in the Treatment of the Lymphatic System and Malignant Disease
Methods of Making Enhanced, Autologous Fat Grafts
Methods of Using Regenerative Cells to Promote Wound Healing
Systems and Methods for Isolating and Using Clinically Safe Adipose Derived Regenerative Cells
Methods of Using Regenerative Cells in the Treatment of Stroke and Related Diseases and Disorders
Methods of Using Adipose-Derived Regenerative Cells in the Treatment of Peripheral Vascular Disease and Related Disorders
Methods of Using Adipose Tissue-Derived Cells in Augmenting Autologous Fat Transfer
Use Adipose Tissue-Derived Regenerative Cells in the Modulation of Inflammation in the Pancreas and in the Kidney
Application:
13/720,829 →
Publication:
US 2013/0108592
Adipose-Derived Regenerative Cells for Treating Liver Injury
Methods of Using Adipose Derived Regenerative Cells in the Treatment of Renal Diseases and Disorders
Methods of Using Regenerative Cells to Treat an Ischemic Wound
Methods of Using Regenerative Cells to Treat a Burn
Methods of Using Adipose Tissue-Derived Cells in the Treatment of the Lymphatic System and Malignant Disease
Methods of Using Regenerative Cells in the Treatment of Cartilage Defects
Methods of Using Regenerative Cells in the Treatment of Erectile Dysfunction
Tissue Transfer System
Application:
14/750,932 →
Publication:
US 2016/0177250
Systems and Methods for Manipulation of Regenerative Cells from Adipose Tissue
Application:
14/860,416 →
Publication:
US 2016/0113967
Systems for Isolating and Using Clinically Safe Adipose Derived Regenerative Cells
Methods of Using Adipose Tissue-Derived Cells in the Modulation of Pain and/or Fibrosis
Application:
14/917,441 →
Publication:
US 2016/0206661
Adipose-Derived Regenerative Cells for Treating Liver Injury
Application:
14/954,584 →
Publication:
US 2016/0143952
Regenerative Cell Therapy for Central Nervous System (Cns) Disorders and Ptsd
Application:
15/117,665 →
Publication:
US 2017/0065638
Methods of Using Regenerative Cells to Promote Epithelialization or Neodermis Formation
Centrifuge Chamber
Application:
15/324,596 →
Publication:
US 2017/0205322
Methods of Using Adipose Tissue-Derived Cells in the Treatment of the Lymphatic System and Malignant Disease
Application:
15/345,294 →
Publication:
US 2017/0114325
Methods of Using Regenerative Cells in the Treatment of Renal Diseases and Disorders
Application:
15/362,249 →
Publication:
US 2017/0136066
Mobile Terminal Having Multi-Function Executing Capability and Executing Method Thereof
Application:
15/362,716 →
Publication:
US 2017/0075537
Cell Carrier and Cell Carrier Containment Devices Containing Regenerative Cells
Application:
15/366,924 →
Publication:
US 2017/0136069
Methods of Using Adipose Tissue-Derived Cells in the Treatment of Cardiovascular Conditions
Application:
15/462,643 →
Publication:
US 2017/0281771
Use of Regenerative Cells in Mitigating Burn Progression and Improving Skin Graft Incorporation and Healing
Application:
15/515,870 →
Publication:
US 2017/0296697
Liposomal Taxanes for Treatment of Sclc
Application:
62/542,993 →
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Dec 3, 2012
From: CYTORI THERAPEUTICS INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 029395/0660 →
Security Agreement
Jun 28, 2013
From: CYTORI THERAPEUTICS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 030715/0625 →
Release of Security Interest
Jul 3, 2013
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: CYTORI THERAPEUTICS, INC.
Reel/Frame 030734/0778 →
Release of Security Interest
Jun 12, 2015
From: OXFORD FINANCE LLC
To: CYTORI THERAPEUTICS, INC.
Reel/Frame 035902/0191 →
Assignment of Assignor's Interest
Apr 27, 2017
From: AZAYA THERAPEUTICS, INC.
To: CYTORI THERAPEUTICS, INC.
Reel/Frame 042167/0373 →
Assignment of Assignor's Interest
Apr 25, 2019
From: CYTORI THERAPEUTICS, INC.
To: LOREM VASCULAR PTE. LTD.
Reel/Frame 049651/0001 →
Release of Security Interest
Apr 25, 2019
From: OXFORD FINANCE LLC
To: CYTORI THERAPEUTICS, INC.
Reel/Frame 049011/0347 →
Assignment of Assignor's Interest
May 17, 2019
From: CYTORI THERAPEUTICS, INC.
To: LOREM VASCULAR PTE. LTD.
Reel/Frame 049313/0434 →
Corrective Assignment to Correct the Correct Assignee's Address Previously Recorded at Reel: 049313 Frame: 0434. Assignor(S) Hereby Confirms the Assignment.
Aug 1, 2019
From: CYTORI THERAPEUTICS, INC.
To: LOREM VASCULAR PTE. LTD.
Reel/Frame 049942/0204 →
Change of Name
Oct 3, 2019
From: CYTORI THERAPEUTICS, INC.
To: PLUS THERAPEUTICS, INC.
Reel/Frame 050616/0677 →
First Amendment to the Intellectual Property Security Agreement
Aug 23, 2022
From: PLUS THERAPEUTICS, INC. (F/K/A CYTORI THERAPEUTICS, INC.)
To: OXFORD FINANCE LLC
Reel/Frame 061302/0335 →
Release of Security Interest
Oct 11, 2024
From: OXFORD FINANCE LLC
To: PLUS THERAPEUTICS, INC.
Reel/Frame 068877/0700 →